BACKGROUND: No prospective cohort study of high-risk children has used rigorous exposure assessment and optimal diagnostic procedures to examine the perinatal antecedents of autism spectrum disorder separately among those with and without cognitive impairment. OBJECTIVE: We sought to identify perinatal factors associated with increased risk for autism spectrum disorder with and without intellectual disability (intelligence quotient <70) in children born extremely preterm. STUDY DESIGN: This prospective multicenter (14 institutions in 5 states) birth cohort study included children born at 23-27 weeks' gestation in 2002 through 2004 who were evaluated for autism spectrum disorder and intellectual disability at age 10 years. Pregnancy information was obtained from medical records and by structured maternal interview. Cervical-vaginal "infection" refers to maternal report of bacterial infection (n ¼ 4), bacterial vaginosis (n ¼ 30), yeast infection (n ¼ 62), mixed infection (n ¼ 4), or other/ unspecified infection (n ¼ 43; eg, chlamydia, trichomonas, or herpes). We do not know the extent to which infection per se was confirmed by microbial colonization. We use the terms "fetal growth restriction" and "small for gestational age" interchangeably in light of the ongoing challenge to discern pathologically from constitutionally small newborns. Severe fetal growth restriction was defined as a birthweight Z-score for gestational age at delivery <e2 (ie, 2 SD below the median birthweight in a referent sample that excluded pregnancies delivered for preeclampsia or fetal indications). Participants were classified into 4 groups based on whether or not they met rigorous diagnostic criteria for autism spectrum disorder and intellectual disability (autism spectrum disorderþ/intellectual disabilitye, autism spectrum disorderþ/intellectual disabilityþ, autism spectrum disordere/ intellectual disabilityþ, and autism spectrum disordere/intellectual disabilitye). Temporally ordered multinomial logistic regression models were used to examine the information conveyed by perinatal factors about increased risk for autism spectrum disorder and/or intellectual disability (autism spectrum disorderþ/intellectual disabilitye, autism spectrum disorderþ/intellectual disabilityþ, and autism spectrum disordere/intellectual disabilityþ). RESULTS: In all, 889 of 966 (92%) children recruited were assessed at age 10 years, of whom 857 (96%) were assessed for autism spectrum disorder; of these, 840 (98%) children were assessed for intellectual disability. Autism spectrum disorderþ/intellectual disabilitye was diagnosed in 3.2% (27/840), autism spectrum disorderþ/intellectual disabilityþ in 3.8% (32/840), and autism spectrum disordere/intellectual disabilityþ in 8.5% (71/840). Maternal report of presumed cervical-vaginal infection during pregnancy was associated with increased risk of autism spectrum disorderþ/intellectual disabilityþ (odds ratio, 2.7; 95% confidence interval, 1.2e6.4). The lowest gestational age category (23-24 weeks) was associated with increased risk of autism spectrum disorderþ/intellectual disabilityþ (odds ratio, 2.9; 95% confidence interval, 1.3e6.6) and autism spectrum disorderþ/intellectual disabilitye (odds ratio, 4.4; 95% confidence interval, 1.7e11). Severe fetal growth restriction was strongly associated with increased risk for autism spectrum disorderþ/intellectual disabilitye (odds ratio, 9.9; 95% confidence interval, 3.3e30), whereas peripartum maternal fever was uniquely associated with increased risk of autism spectrum disordere/intellectual disabilityþ (odds ratio, 2.9; 95% confidence interval, 1.2e6.7). CONCLUSION: Our study confirms that low gestational age is associated with increased risk for autism spectrum disorder irrespective of intellectual ability, whereas severe fetal growth restriction is strongly associated with autism spectrum disorder without intellectual disability. Maternal report of cervical-vaginal infection is associated with increased risk of autism spectrum disorder with intellectual disability, and peripartum maternal fever is associated with increased risk for intellectual disability without autism spectrum disorder.
Introduction
Meta-analyses and comprehensive reviews describe inconsistencies in research findings on the perinatal antecedents of autism spectrum disorder (ASD) as likely reflecting study differences in ascertainment and diagnostic procedures, sample size, exposure assessment, and treatment of potential confounders. [1] [2] [3] Nevertheless, mounting evidence suggests that a constellation of perinatal factors contribute to increased risk of ASD, including preterm birth, [4] [5] [6] [7] [8] [9] fetal growth restriction (or lower than expected birthweight for gestational age 10 ), 4, 6 and their correlates (eg, placental insufficiency and preeclampsia). 11 Risk factors for ASD apparently differ between children who have and who do not have co-occurring intellectual impairment (intellectual disability [ID] ). 4, 7, 12 Yet, no prospective cohort study of high-risk children has used rigorous exposure assessment and optimal diagnostic procedures to examine the perinatal antecedents of ASD, taking into account co-occurring cognitive impairment. The large Extremely Low Gestational Age Newborn (ELGAN) Study cohort of infants born <28th week of gestation afforded us the opportunity to examine prospectively the antenatal and neonatal antecedents of ASD diagnosed at age 10 years, separately in children with and without co-occurring ID (intelligence quotient [IQ] <70).
Materials and Methods Participants
The ELGAN Study is a multicenter observational study designed to identify characteristics and exposures associated with increased risk of structural and functional neurologic disorders in extremely preterm infants. 13 During the years 2002 through 2004, women delivering <28 weeks' gestation at 1 of 14 participating institutions were asked to enroll in the study; 1249 mothers of 1506 infants consented to participate, and 1198 children survived to 10 years (see Supplemental Figure 1 for a flow diagram of study participants). Of 966 children who were actively recruited for follow-up at age 10 years (because of the availability of blood samples from their first postnatal month), informed consent was obtained for the participation of 889 (92%). The institutional review boards of participating institutions approved the study procedures.
Demographic, pregnancy, delivery, and newborn variables
Methods of data collection for demographic, pregnancy, delivery, and newborn variables are described elsewhere, 13 and in detail in the Supplement. In brief, gestational age estimates were based on a hierarchy of the best information available as described in the Supplement (92% were based on fetal ultrasound; most <14 weeks). Cervicalvaginal "infection" refers to maternal report of bacterial infection (n ¼ 4), bacterial vaginosis (n ¼ 30), yeast infection (n ¼ 62), mixed infection (n ¼ 4), or other/unspecified infection (n ¼ 43; eg, chlamydia, trichomonas, or herpes). Previous research indicates that such information gained through selfreport can be more accurate than that obtained from medical records or birth certificates, 14-17 but we do not know the extent to which infection per se was confirmed by microbial colonization. The terms "fetal growth restriction" and "small for gestational age: meet our needs equally, and we use them interchangeably since accurate differentiation of pathologically from constitutionally small newborns 18, 19 is an ongoing challenge. [20] [21] [22] Severe fetal growth restriction was defined by a birthweight Z-score <e2. Birthweight Z-score was calculated as the number of SD each infant's birthweight was above or below the median birthweight in referent samples that excluded pregnancies delivered for preeclampsia or fetal indications. 23, 24 Physiology, laboratory, and therapy data for the first 12 postnatal hours were collected to calculate a Score for Neonatal Acute Physiology-II. 25, 26 Additional data were collected on placenta microbiology and histology, [27] [28] [29] [30] [31] mode of ventilation and respiratory care, 32, 33 bacteremia, 34 patent ductus arteriosis, 35 illnesses and medications used in the first 28 days postpartum, 36 necrotizing enterocolitis, 37 and retinopathy. 38 
Assessment at 10 years of age
The assessment procedures, and all relevant test scores for ASD and ID, are reported in a prior publication. 39 Briefly, diagnostic assessment of ASD was conducted with 3 well-validated measures, administered sequentially. First was the Social Communication Questionnaire (SCQ) with a screen-in score 11 to increase sensitivity relative to the standard criterion score of 15.
40 Children who met the SCQ criterion were then assessed with the Autism Diagnostic IntervieweRevised (ADI-R). 41 All children who met ADI-R criteria for autism or ASD, 42 or who had a prior clinical diagnosis of ASD and/or exhibited symptoms of ASD during cognitive testing according to the site psychologist were then assessed with the Autism Diagnostic Observation Schedule, Second Version (ADOS-2) 43 ethe criterion measure of ASD in this study.
All ADOS-2 administrations were independently scored by a second rater with autism diagnostic and ADOS-2 expertise (R.M.J.) who did not have knowledge of the child's SCQ and ADI-R results or clinical history. In cases of scoring disagreements, consensus was reached between raters. Item-by-item interrater agreement for the 14 ADOS-2 diagnostic algorithm scores was on average .93 (SD ¼ .12). Of 90 ADOS-2 assessments, interrater disagreement and consensus scoring resulted in 4 changes of classification, 3 from non-ASD to ASD and 1 from ASD to non-ASD (Cohen kappa ¼ .90).
Intellectual ability (IQ) was assessed with the School-Age Differential Ability Scales-II. 44 Children with IQ [(verbal þ nonverbal reasoning scores)/2] <70 were classified as having ID. Because ASD cannot be validly diagnosed in children with significant visual and/or motor impairment accompanied by severe ID, 45 children with these conditions were excluded from diagnostic consideration of ASD (Supplemental Figure 1) . Severe gross motor dysfunction was defined as level 5 (ie, no self-mobility) on the Gross Motor Function Classification System. 46 A child was considered to have severe visual impairment if the parent reported uncorrectable functional blindness in both eyes. No participant had a significant, uncorrected hearing impairment.
Data analyses
We evaluated the null hypothesis that ASDþ/IDe, ASDþ/IDþ, and ASDe/ IDþ are not associated with any maternal, pregnancy, delivery, or postnatal characteristic or exposure. We began by classifying children into 4 groups based on whether or not they met diagnostic criteria for ASD and ID at age 10 years. We then described the percent of children in each group whose mother had selected demographic and pregnancy characteristics or who themselves had perinatal and neonatal characteristics and exposures and who were ajog.org OBSTETRICS Original Research diagnosed with ASD and/or ID at age 10 years.
Because antepartum phenomena can influence postnatal phenomena, we tested our null hypothesis with temporally oriented models. 47 Primary exposures included inflammation-related phenomena during pregnancy (eg, maternal report of cervical-vaginal infection) and at delivery (eg, intrapartum maternal fever), indicators of fetal growth restriction and its correlates (eg, birthweight Z-score for gestational age <e2 and preeclampsia), and lowest gestational age category (ie, 23-24 weeks). We considered variables as confounders if identified in the literature or if in our data they were associated with both the exposure and the outcome with probabilities .25.
48
To construct the time-oriented models, we used a step-down procedure seeking a parsimonious solution without effect modification terms. First, we examined pregnancy information in a multinomial logistic regression model of risk for ASD and ID. Then we added factors measured around the time of delivery, adjusting for those variables with statistically significant associations in the pregnancy-stage model. Finally, we added neonatal factors, adjusting for all variables selected in by the earlier models.
We present magnitudes of association as odds ratios (OR) with 95% confidence intervals (CI). Associations were statistically significant when the 95% CI did not include the null estimate (ie, OR, 1.0). The primary outcomes ASDþ/IDe and ASDþ/IDþ affected 3-4% of our sample of ELGANs, giving us 80% power to detect associations with a minimal detectable OR of 3.2, assuming an exposure prevalence of 0.3. We also describe the prevalence and antecedents of ID without ASD as a secondary outcome.
Results
Of the 996 children recruited to participate at age 10 years, 889 (92%) were enrolled, of whom 840 (95%) were assessed both for ASD and for ID (Supplemental Figure 1) . Of the 840 children in our final sample, 7.0% (n ¼ 59) met study criteria for ASD and 12.3% (n ¼ 103) had ID (IQ <70). 
Descriptive univariate analyses
The results of univariate analyses are displayed visually using the same format in Figures 
Maternal demographic characteristics
Percent of children whose mother had selected demographic characteristics classified at age 10 years as autism spectrum disorder (ASD)þ/intellectual disability (ID)e, ASDþ/IDþ, ASDe/IDþ, or ASDe/IDe. Women who identified as black, did not graduate from high school (HS), and/or were eligible for government-provided health care (public) insurance gave birth to children who later had ASDe/IDþ or ASDþ/IDþ more frequently than other women.
groups; dotted vertical lines proceeding downward from each symbol through the plot are provided to enable easy visual comparison between cohort prevalence and each plotted percent (ie, prevalence among study groups formed according to pregnancy, birth, and neonatal characteristics). The total number of children who had or were exposed to each characteristic is shown on the right vertical axis. We describe maternal demographic characteristics in Figure 1 ; maternal exposures, illnesses, and medications in Figure 2 ; pregnancy characteristics and complications in Figure 3 ; and newborn characteristics in Figure  4 .
Supplemental Figures 2 to 5 illustrate placenta characteristics, early postnatal characteristics, newborn medications and therapies, and newborn diagnoses and dysfunctions. The accompanying legends provide brief descriptions of the distribution of ASD/ID study groups shown in each figure to represent the entire study population.
Analytic multivariable regression analyses
Time-ordered multinomial logistic regression models (Table) were used to examine the extent to which pregnancy, delivery, and neonatal factors are associated with increased risk for ASDþ/ IDe, ASDþ/IDþ, or ASDe/IDþ, adjusting for potential confounders.
Children were at increased risk of ASDþ/IDe if they were born in the lowest gestational age category (OR, 4.4; 95% CI, 1.7e11) and if they had severe fetal growth restriction (birthweight Zscore <e2) (OR, 9.9; 95% CI, 3.3e30). Maternal fever at delivery was associated with 3.6 times greater risk of ASDþ/ IDe, although the association was not quite statistically significant (OR, 3.6; 95% CI, 0.98e13). The mother's receipt of an antibiotic during the pregnancy was associated with reduced risk of ASDþ/ IDe (OR, 0.1; 95% CI, 0.01e0.7).
Children were at increased risk of ASDþ/IDþ if the mother reported a cervical-vaginal infection during pregnancy (OR, 2.7; 95% CI, 1.2e6.4), if they were boys (OR, 2.9; 95% CI, 1.3e6.8), or if their gestational age was in the lowest category (23-24 weeks) (OR, 2.9; 95% CI, 1.3e6.6).
Risk factors for ID unaccompanied by ASD included maternal fever at delivery (OR, 2.9; 95% CI, 1.2e6.7), male sex (OR, 2.1; 95% CI, 1.2e3.6), and very low gestational age (OR, 1.8; 95% CI, 1.03e3.3).
Comment
In a large, prospectively followed up cohort of children born <28th week of gestation, we found that low gestational age is a risk factor for rigorously diagnosed ASD irrespective of IQ <70 or 70, severe fetal growth restriction (ie, birthweight Maternal exposures, illnesses, and medications Percent of children whose mother had selected pregnancy characteristics or exposures classified at age 10 years as autism spectrum disorder (ASD)þ/intellectual disability (ID)e, ASDþ/IDþ, ASDe/ IDþ, or ASDe/IDe. Children whose mother reported vaginal/cervical infection and/or periodontal infection during this pregnancy had ASDþ/IDþ more frequently than children of other women. By contrast, children of women who consumed antibiotics less frequently received diagnosis of ASDþ/ IDe compared to children of other women, whereas ASDe/IDþ occurred more frequently among children born to women who reported fever during this pregnancy than in children of other women. ajog.org OBSTETRICS Original Research Z-score <e2) is strongly associated with increased risk of ASDþ/IDe, and maternal report of cervical-vaginal infection is strongly associated with increased risk of ASDþ/IDþ. In addition, prescription of an antibiotic is associated with lowered risk of ASDþ/IDe, and peripartum maternal fever is associated with increased risk of ASDe/IDþ.
Our study confirms previous observations that preterm birth is associated with increased risk of ASD, 4, 6, 7 and that the risk increases as gestational age decreases, 5 even among children born in the narrow window of 23-27 weeks of gestation. The only prior study of ASD risk specifically among extremely preterm children did not find an association between gestational age and ASD, 8 perhaps because it was based on only 16 diagnosed children, and because of the relatively restricted range of gestational age (<26 weeks) of the study sample.
Very low gestational age is associated with increased risk not only for ASD with ID, but also for ASD with relatively intact or normal cognitive function. Some of the increased risk might reflect vulnerability of cerebral maturation processes, 49 paucity of neuroprotective factors, 50 postnatal physiologic instability, 51 and/or inflammatory phenomena that appear to increase the risk of brain damage in very preterm newborns. 52 Lower than expected birthweight for gestational age, 4 and its correlates (ie, preeclampsia, placental insufficiency, and cesarean delivery 11 ) have also been associated with increased risk of ASD. 10 We use the terms "fetal growth restriction" and "small for gestational age" interchangeably, since the accurate differentiation of pathologically small from constitutionally small newborns 18, 19 is an ongoing challenge. [20] [21] [22] Our findings are novel in indicating that impaired fetal growth among extremely preterm newborns is the factor most strongly associated with ASD among children without cognitive impairment. The cooccurrence of severe growth restriction with very preterm birth might result in double jeopardy, 53 placing children with both characteristics at especially high risk of developmental disability, perhaps due to the tendency of such children to have a more intense systemic inflammatory response compared to their peers who are not growth restricted. 54 The strong association of fetal growth restriction with ASD might also reflect epigenetic phenomena. Not only is fetal growth restriction strongly associated with developmental programming that has been attributed to DNA methylation 55, 56 and histone acetylation, 57 ASD has also been associated with epigenetic changes. [58] [59] [60] Here, too, double jeopardy might come into play because epigenetic phenomena 
Pregnancy characteristics and complications
Percent of children whose mother had selected pregnancy complications classified at age 10 years as autism spectrum disorder (ASD)þ/intellectual disability (ID)e, ASDþ/IDþ, ASDe/IDþ, or ASDe/IDe. Irrespective of their intelligence quotient (IQ), children whose mother had preeclampsia and/or received magnesium sulfate for seizure prophylaxis developed ASD more frequently than children of other mothers. Children born to women who had placental abruption, and those whose mother had fever within 48 hours before or after delivery, more frequently developed ASDþ/IDe than children of other mothers.
WBC, white blood cell count. have also been associated with inflammation. [61] [62] [63] [64] Our finding that maternal report of cervical-vaginal infection in pregnancy and peripartum maternal fever are associated with ID with and without ASD adds further support to the role of immune responses in the genesis of perinatal brain disorders. 24, 65, 66 We do not know the extent to which maternal reported cervical-vaginal infections involved a documented immune response to microbial colonization (ie, true infection). Previous research indicates that information gained through self-report during maternal interview can be more accurate than that obtained from medical records or birth certificates, [14] [15] [16] [17] although modest reliability has also been reported for some obstetric morbidity surveys. 67, 68 In the ELGAN Study, newborns whose mother reported a genitourinary infection during pregnancy were more frequently exposed to inflammation of the chorionic plate, chorion, decidua, fetal stem vessels, and umbilical cord than were those whose mother did not. 69 These children also had higher neonatal blood concentrations of inflammation-associated proteins than other newborns. 70 Likewise, prior studies suggest that children with ASD diagnoses or autistic mannerisms are more frequently exposed to certain viruses and higher titers of antibodies to these viruses, 71, 72 have elevated peripheral blood or dried newborn blood spot concentrations of some inflammation-related proteins, 73 and have higher rates of immune-mediated conditions than other children. 74 Preclinical evidence additionally supports the view that perinatal inflammationinitiating conditions make the brain more vulnerable to subsequent insults, and that the timing of an inflammatory exposure might alter the course of subsequent brain injury. 66 Very preterm delivery for maternal or fetal indications is associated with a higher risk of ASDþ/IDþ than is delivery for spontaneous indications. Because women who deliver for maternal or fetal indications are less likely to receive antibiotics than women who deliver for spontaneous indications, 75 it is possible that the variable for receipt of antibiotics conveys information about spontaneous preterm deliveries, which were at reduced risk of ASD without ID. Thus, the receipt of antibiotics may merely be an indicator or correlate of reduced risk that is not involved in lowering risk.
Strengths and limitations
Strengths of our study include the large, prospectively followed up cohort of infants enrolled on the basis of gestational age rather than birthweight, 76 and confirmation of the diagnosis of ASD at age 10 years with rigorous diagnostic procedures. As with all observational studies, we were limited in our ability to FIGURE 4 Newborn characteristics Percent of newborns with selected characteristics who were classified at age 10 years as autism spectrum disorder (ASD)þ/intellectual disability (ID)e, ASDþ/IDþ, ASDe/IDþ, or ASDe/IDe. Boys had ASDþ/IDþ and ASDþ/IDe twice as frequently as girls. Prevalence of ASD increased with decreasing gestational age and, to lesser extent, with decreasing birthweight, regardless of intelligence quotient (IQ). Children who had birth head circumference Z-score <e2 also received ASD diagnoses more frequently than other children, irrespective of IQ. Children with most severe fetal growth restriction (ie, birthweight Z-score <e2) had highest percent of ASDþ/IDe diagnoses. Antecedents of ASDe/ IDþ included male sex, low gestational age, and fetal growth restriction (including microcephaly).
Data from [23] . ajog.org OBSTETRICS Original Research infer causation from associations. While ASD was more prevalent in our sample of ELGANs than in the general population, only 3.8% of our sample had ASD with ID, and 3.2% had ASD without ID. As a consequence, our analyses had adequate statistical power to detect only relatively strong underlying associations. Nonetheless, we did identify a number of antecedents associated with both of these outcomes.
Conclusions and relevance
Among children born <28th week of gestation, those who were in the lowest gestational age category were at increased risk of ASD irrespective of co-occurring ID, whereas severe fetal growth restriction was strongly associated with increased risk of ASD without ID, and cervical-vaginal infection was specifically associated with increased risk of ASD with ID. Peripartum maternal fever was uniquely associated with increased risk of cognitive impairment not accompanied by ASD. These findings support other evidence that immaturity, epigenetic phenomena, and inflammation contribute to the occurrence of ASD. n Figures 1e5) After delivery, a trained research nurse interviewed each mother following a structured procedure. Maternal report of personal history, sociodemographics, exposures during pregnancy, and sequence of events leading to preterm delivery were accepted as the primary source when discrepant information was reported in the medical record. Previous research has shown that such information gained through self-report is more accurate than that obtained from medical records or birth certificates. [1] [2] [3] [4] Following the mother's discharge, the research nurse reviewed the maternal chart using a structured data collection form to collect information about events after admission. The 6 initiators of preterm delivery (preterm labor, preterm premature rupture of the fetal membranes, placental abruption, cervical insufficiency, preeclampsia, and delivery for fetal indications) are defined elsewhere. 5 
Gestational age
The gestational age estimates were based on a hierarchy of the quality of available information. Most desirable were estimates based on the dates of embryo retrieval or intrauterine insemination or fetal ultrasound <14th week (62%). When these were unavailable, reliance was placed sequentially on a fetal ultrasound at 14 weeks (29%), last menstrual period (7%), and gestational age recorded in the log of the neonatal intensive care unit (1%).
Birthweight Z-score
Birthweight Z-scores were calculated as the number of SD each infant's birthweight was above or below the median birthweight in a referent sample that excluded pregnancies delivered for preeclampsia or fetal indications. 6, 7 Score for Neonatal Acute Physiology II
We collected all the physiology, laboratory, and therapy data for the first 12 neonatal hours needed to calculate a Score for Neonatal Acute Physiology II. 8 
Placentas
Delivered placentas were placed in a sterile exam basin and biopsied under sterile conditions. Of the samples, 82% were obtained within 1 hour of delivery. The microbiologic procedures are described in detail elsewhere, 9, 10 as are the histologic procedures.
9,11

Mode of ventilation
Mode of ventilation was defined as the highest level of support on each day and ranged from no support, increased ambient oxygen in a hood, nasal cannula, nasal continuous positive airway pressure, and conventional mechanical ventilation to high-frequency ventilation. After the first week, this information was collected on days 7, 14, 21, and 28, and at 36 weeks postmenstrual age. We also recorded the number of days each infant received supplemental oxygen, continuous positive airway pressure, and conventional mechanical ventilation (including high-frequency ventilation). Details about blood gases obtained during the first 3 postnatal days and on postnatal days 7 and 14 are provided elsewhere, 12, 13 as are details about the 3 mutually exclusive respiratory dysfunction groups: consistently low fraction of inspired oxygen, pulmonary deterioration, and early and persistent pulmonary dysfunction. 14 
Bacteremia
Documented early bacteremia was defined as recovery of an organism from blood drawn during the first week, and late bacteremia as recovery of an organism from blood drawn during weeks 2, 3, or 4.
15, 16 We did not collect data on specific organisms recovered from blood. A diagnosis of a tracheal infection required the recovery of a pathogen from a tracheal aspirate. An infection (whether blood, trachea, or cerebrospinal fluid) was identified as clinically suspected if no organism was recovered and a clinician treated the baby with antibiotics.
Patent ductus arteriosus
The diagnosis of patent ductus arteriosus was assigned by clinicians without uniformity of definition; confirmation by echocardiography was recorded. Diagnoses of pneumothorax, pulmonary interstitial emphysema, and pulmonary hemorrhage were those made by the clinicians caring for the extremely low gestational age newborn.
Neonatal medications
Medications were recorded if given on any day during the first 28 days of life and included methylxanthines (aminophylline, theophylline, caffeine), analgesics (ie, morphine, fentanyl, or methadone), sedatives (ie, lorazepam, midazolam, or chloral hydrate), and steroids (ie, hydrocortisone and dexamethasone). Information on class and dosage of medications was not collected.
Respiratory care
After discharge, details were collected about the apparent need for respiratory care at 36 weeks' postmenstrual age along with discharge diagnoses. The diagnosis of bronchopulmonary dysplasia/chronic lung disease was based on receipt of supplemental oxygenation at 36 weeks' postmenstrual age. Severe bronchopulmonary dysplasia was defined as receipt of both supplemental oxygen and mechanical ventilation assistance.
17,18
Necrotizing enterocolitis
The child's necrotizing enterocolitis status was classified according to the modified Bell staging system. 19 
Retinopathy
Retinopathy was defined within the 31st-33rd postmenstrual week according to the guidelines of the International Committee for Classification of Retinopathy of Prematurity. 20 Follow-up exams were conducted as clinically indicated until normal vascularization began in zone III of the retina.
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